Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;38(2):388-94.
doi: 10.1007/s11096-016-0259-8. Epub 2016 Jan 30.

Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients

Nazan Yuce-Artun  1 , Bora Baskak  2 , Erguvan Tugba Ozel-Kizil  2 , Hatice Ozdemir  3 , Zuhal Uckun  4 , Halise Devrimci-Ozguven  5 , Halit Sinan Suzen  6
Affiliations

Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients

Nazan Yuce-Artun et al. Int J Clin Pharm. 2016 Apr.

Abstract

Background: Genetic polymorphisms in CYP2B6 and CYP2C19 may cause variability in the metabolism of sertraline, a widely used antidepressant in major depressive disorder treatment.

Objective: This study investigates the impact of CYP2B6*4 (785A > G), CYP2B6*9 (516G > T), CYP2B6*6 (516G > T + 685G > A) CYP2C19*2 (685G > A), CYP2C19*17 (-3402C > T) polymorphisms on plasma concentrations of sertraline and N-desmethyl sertraline in major depression patients treated with sertraline [n = 50].

Setting: Participants were patients who admitted to an adult psychiatry outpatient unit at a university hospital. These were DSM-IV major depression diagnosed patients with a stable sertraline medication regimen [for at least one month].

Methods: CYP2B6*4 (rs 2279343; 785A > G), CYP2B6*9 (516G > T; rs 3745274), CYP2B6*6 (516G > T + 685G > A) CYP2C19*2 (rs 4244285; 685G > A), CYP2C19*17 (rs 11188072; -3402C > T), polymorphisms were analyzed by polymerase chain reaction and restriction fragment length polymorphism. Plasma concentrations were measured by high-performance liquid chromatography in patients treated with SERT.

Main outcome measure: The distribution of CYP2B6*4, *6, *9 and CYP2C19*2, *17 among patient group and the association between genotype and sertraline metabolism.

Results: Sertraline, N-desmethyl sertraline, N-desmethyl sertraline/sertraline and dose-adjusted plasma concentrations were statistically compared between individuals with wild-type and variant alleles both for CYP2B6 and CYP2C19 enzymes. The mean N-desmethyl sertraline/sertraline value, was significantly lower in all subgroups with *6 and *9 variant alleles (p < 0.05). Sertraline/C values were significantly higher (p < 0.05) and N-desmethyl sertraline/C values were lower in all subgroups with *6 and *9 variant alleles compared to wild-type subgroup.

Conclusion: CYP2B6*6 and *9 variant alleles had a significant decreasing effect on sertraline metabolism in major depression patients which might result as variations in sertraline therapy.

Keywords: CYP2B6; CYP2C19; Cytochrome P450; Pharmacogenetics; Sertraline.

PubMed Disclaimer

References

    1. Clin Pharmacol Ther. 2006 Jan;79(1):103-13 - PubMed
    1. Dialogues Clin Neurosci. 2010;12(1):69-76 - PubMed
    1. Clin Pharmacokinet. 2009;48(12):761-804 - PubMed
    1. Drug Metab Dispos. 1999 Jul;27(7):763-6 - PubMed
    1. Br J Clin Pharmacol. 1999 Sep;48(3):416-23 - PubMed

Publication types

LinkOut - more resources